Tango Therapeutics Inc.

Analysts Viewpoint

Tango Therapeutics Inc’s recent filing unveils that its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18

Stock Earnings

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Tango Therapeutics

Insiders Updates

Tango Therapeutics Inc’s filing revealed that its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18 ’24.

Analysts Viewpoint

In a filing, Tango Therapeutics Inc revealed its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18

Insiders Updates

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

In a filing, Tango Therapeutics Inc revealed its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Tango Therapeutics Inc’s recently made public that its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18

Stock Earnings

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Tango Therapeutics Inc’s recently made public that its Director Rothenberg Mace acquired Company’s shares for reported $37800.0 on Nov 18

Tag: Tango Therapeutics Inc.